Mastery EAQ Ch. 34

A  Strong contractions

B  Decreased pain

C  Midline fundus

D  Softened cervix

A  Pulmonary embolism

B  Renal failure

C  Ovarian failure

D  Abnormal vaginal bleeding

A  Hirsutism, Bradycardia, Increased diuresis

B  Anxiety, Dizziness, Blurred vision

C  Blurred vision, Bradycardia, Increased diuresis

D  Hirsutism, Dizziness,, Increased diuresis

A  During the entire period the patient is taking the antibiotic

B  Until three throat cultures have been negative for the pathogen

C  For at least 1 month after starting the antibiotic

D  For at least 6 weeks, starting at the end of the antibiotic regimen

A  Alendronate

B  Megestrol

C  Methylergonovine

D  Estradiol

A  Calcium gluconate

B  Epinephrine

C  Protamine sulfate

D  Atropine

A  Request a prescription to give calcium gluconate.

B  Obtain a prescription for terbutaline.

C  Obtain a prescription for indomethacin.

D  Decrease the drug dose immediately.

A  Place the patient on her left side.

B  Administer phentolamine mesylate.

C  Immediately discontinue intravenous (IV) fluids.

D  Instruct the patient to bear down and push.

A  Monitor the patient for blurred vision. Monitor blood pressure during administration. Administer it before placenta delivery. Question the prescription if the patient has liver disease.

B  Monitor the patient for blurred vision. Administer it before placenta delivery. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

C  Monitor the patient for blurred vision. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

D  Administer it before placenta delivery. Monitor blood pressure during administration. Assess for pelvic inflammatory disease. Question the prescription if the patient has liver disease.

A  Uterine atony

B  Hypertension

C  Nausea and vomiting

D  Pelvic inflammatory disease

A  Temperature

B  Blood pressure

C  Blood glucose

D  Uterine contractions

A  Ineffective contractions in a full-term pregnancy

B  Vaginal bleeding at 38 weeks’ gestation

C  Radiographic confirmation of cephalopelvic disproportion

D  Absence of cervical ripening at 42 weeks’ gestation

A  Use of herbal supplements

B  Current tricyclic antidepressant use

C  Cigarette use

D  Low fluid intake

A  Uterine hyperactivity, Fetal heart rate, Complete blood cell count

B  The patient’s blood pressure and pulse, Complete blood cell count, Uterine hyperactivity

C  Fetal movement, Uterine hyperactivity, Complete blood cell count

D  Fetal heart rate, Fetal movement, The patient’s blood pressure and pulse

A  Denosumab

B  Ibandronate

C  Calcitonin

D  Tamoxifen

A  Inform the patient about the benefits and risks of the therapy.

B  Persuade the patient to start the therapy.

C  Advise the patient to engage in quiet activities.

D  Ask the patient to include soy in her diet.

A  “You may need to stop smoking during the therapy.”

B  “The treatment should be started as soon as possible.”

C  “The therapy may cause thromboembolic events.”

D  “The treatment is likely to cause endometrial cancer.”

A  Ritodrine

B  Magnesium sulfate

C  Terbutaline

D  Bed rest and hydration

A  Hypertension

B  Diabetes

C  Anticonvulsant therapy

D  Antibiotic therapy

A  Male condom with spermicidal jelly

B  Medroxyprogesterone

C  Norethindrone and ethinyl estradiol

D  Cervical cap with spermicidal jelly

A  Current smoker

B  Joint pain

C  Allergy to salmon

D  Breast cancer

A  “Space the medications 1 to 2 hours apart.”

B  “Replace the bisphosphonate with calcitonin.”

C  “Discontinue the calcium supplement.”

D  “Obtain a prescription for increasing the bisphosphonate dose.”

A  “Have tests for serum cholesterol.”

B  “Report missed menstrual periods.”

C  “Have a yearly mammogram.”

D  “Perform weight-bearing exercise.”

A  “Surges of Gn-RH, follicle-stimulating hormone, and luteinizing hormone stimulate ovulation.”

B  “High progesterone levels inhibit the release of luteinizing hormone.”

C  “Decreased Gn-RH suppresses the release of follicle-stimulating hormone.”

D  “Estrogen levels inhibit the release of follicle-stimulating hormone.”

A  “I no longer experience hot flashes.”

B  “I have not experienced any uterine bleeding.”

C  “I have seen a great improvement in my sexual desire.”

D  “I am no longer experiencing painful intercourse.”

A  Amoxicillin

B  Ferritin

C  Metformin

D  Levothyroxine

A  Promotes bone absorption of calcium

B  Stimulates estrogen receptors on the bone to increase bone density

C  Inhibits osteoclast-mediated bone reabsorption

D  Contains estrogen, which stimulates bone reabsorption

A  Warfarin, Cholestyramine

B  Atenolol, Levothyroxine

C  Multivitamin, Atenolol

D  Levothyroxine, Multivitamin

A  “I need to decrease my intake of dairy products to prevent hypercalcemia.”

B  “I need to take this medication with food to prevent damage to my esophagus.”

C  “I will take the medication on an empty stomach and not lie down for 30 minutes.”

D  “This medication will help relieve the bone pain I have from my osteoporosis.”

A  Vertigo, Joint pain, Chest pain

B  Hot flashes, Vertigo, Loss of appetite

C  Chest pain, Hot flashes, Loss of appetite

D  Hot flashes, Loss of appetite, Joint pain

A  To terminate pregnancy

B  To treat gestational hypertension

C  To induce cervical ripening

D  To treat pelvic inflammatory disease

A  Sedentary lifestyle

B  Consumption of saturated fats

C  Smoking heavily every day

D  Increased body mass index (BMI)

A  Estradiol with progestin increases the risk of endometrial cancer.

B  Estrogen monotherapy increases the risk of breast cancer.

C  Unopposed estrogen increases the risk of endometrial cancer.

D  Monotherapy with a progestin increases breast cancer risk.

A  Clomiphene

B  Oxytocin

C  Terbutaline

D  Prostaglandin E

A  Estropipate

B  Megestrol

C  Estrone

D  Medroxyprogesterone

A  Yellow undertone to the skin

B  Brown discoloration of face

C  Hot flashes

D  Loss of hair

A  Administer acetaminophen as needed.

B  Monitor the patient’s blood pressure frequently.

C  Assess pulse oximetry continuously.

D  Suggest the patient take aluminum hydroxide with the medication.

A  Dinoprostone

B  Clomiphene

C  Oxytocin

D  Indomethacin

A  Progesterone

B  Ethinyl estradiol

C  Choriogonadotropin alfa

D  Clomiphene

A  Weight loss

B  Dysmenorrhea

C  Uterine bleeding

D  Deep vein thrombosis

A  “Endometrial cancer risk can be reduced by adding progestin.”

B  “Vaginal cancer is prevented by adding progestin to the regimen.”

C  “The progestin in the regimen will help prevent breast cancer.”

D  “The progestin in the regimen will help prevent ovarian cancer.”

A  Diminished endometrial tissue proliferation

B  Interference with the proliferation of the fertilized ovum

C  Inhibition of the release of gonadotropins

D  Elevated progesterone levels inhibiting the release of the luteinizing hormone

A  Antidiuretic hormone

B  Luteinizing hormone

C  Adrenocorticotropic hormone

D  Follicle-stimulating hormone

A  Thrombophlebitis

B  Dysmenorrhea

C  Hypertension

D  Weight gain

A  Dry skin

B  Weight loss

C  Nausea

D  Higher-pitched voice

A  Premature labor

B  Postpartum hemorrhage

C  Accelerated labor

D  Termination of pregnancy

A  Alendronate

B  Medroxyprogesterone

C  Megestrol

D  Esterified estrogens

A  Phase 4

B  Phase 3

C  Phase 2

D  Phase 1

A  Monophasic

B  Triphasic

C  Biphasic

D  Extended-cycle

A  Follicle-stimulating hormone (FSH)

B  Interstitial cell-stimulating hormone

C  Luteotropic hormone

D  Luteinizing hormone (LH)

A  Methylergonovine

B  Medroxyprogesterone acetate

C  Indomethacin

D  Megestrol

A  Methylergonovine

B  Magnesium sulfate

C  Terbutaline

D  Oxytocin

A  Megestrol

B  Methylergonovine

C  Clomiphene

D  Raloxifene

A  Day 7

B  Day 21

C  Day 14

D  Day 3

A  Luteinizing hormone (LH)

B  Follicle-stimulating hormone (FSH)

C  Adrenocorticotropic hormone

D  Antidiuretic hormone

A  The contractions can be fatal to the patient.

B  The fetal heart rate is stable.

C  The patient is ready for delivery.

D  The patient’s blood pressure is stable.

A  Current smoking status

B  Current use of medications for depression

C  Presence of abnormal uterine bleeding

D  Compliance with the fertility drugs

A  Dementia, Ovarian cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events

B  Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Ovarian cancer

C  Dementia, Breast cancer, Cigarette smoking, Cardiovascular disease, Serious cardiovascular events

D  Dementia, Breast cancer, Ovarian cancer, Cardiovascular disease, Serious cardiovascular events